Rezolute, Inc. (RZLT): Total Liabilities
$12.16M
As of 2026-06-30
+17.2%
3-year compound annual growth
-5.9%
5-year compound annual growth
+19.0%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $12.16M | -9.0% | 2026-09-24, Balance as of period end |
| 2025-06-30 | $13.36M | +13.9% | 2026-09-24, Balance as of period end |
| 2024-06-30 | $11.73M | +55.4% | 2025-09-17, Balance as of period end |
| 2023-06-30 | $7.55M | +156.0% | 2024-09-19, Balance as of period end |
| 2022-06-30 | $2.95M | -82.1% | 2023-09-14, Balance as of period end |
| 2021-06-30 | $16.51M | +358.6% | 2022-09-15, Balance as of period end |
| 2020-06-30 | $3.60M | -65.7% | 2021-09-15, Balance as of period end |
| 2019-06-30 | $10.50M | +62.4% | 2020-10-13, Balance as of period end |
| 2018-06-30 | $6.46M | +207.7% | 2019-09-10, Balance as of period end |
| 2017-06-30 | $2.10M | -1.4% | 2018-10-15, Balance as of period end |
| 2016-06-30 | $2.13M | -3.6% | 2017-09-22, Balance as of period end |
| 2015-06-30 | $2.21M | +121.4% | 2016-09-28, Balance as of period end |
| 2014-06-30 | $997.9K | -81.1% | 2015-09-28, Balance as of period end |
| 2013-06-30 | $5.27M | +123.4% | 2014-09-30, Balance as of period end |
| 2012-06-30 | $2.36M | n/a | 2013-09-11, Balance as of period end |
| 2011-12-31 | $1.46M | n/a | 2013-09-11, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Rezolute, Inc. (RZLT) | 2026-06-30 | $12.16M | -9.0% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $62.07M | -5.7% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $71.79M | +15.1% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $15.74M | +48.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $11.85M | -22.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $10.55M | +95.6% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $401.34M | +14.5% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $70.10M | +362.3% |
Compare RZLT, KRRO, MIST, RFL side by side · Screen every company in Pharmaceutical Preparations ↗